本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Reata製藥

172.36
+0.0000
成交量:- -
成交額:- -
市值:65.66億
市盈率:-72.69
高:172.36
開:172.36
低:172.36
收:172.36
資料載入中...
2023/09/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/24

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/08/08

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2023/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/08/02

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/31

重要事件披露

Form 8-K - Current report
2023/07/31

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/07/28

重要事件披露

Form 8-K - Current report
2023/07/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2023/07/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities